Literature DB >> 16618829

Beta2-adrenergic receptor polymorphisms and sudden cardiac death: a signal to follow.

Stephen B Liggett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16618829     DOI： 10.1161/CIRCULATIONAHA.105.618967

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

1.  beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease.

Authors:  Krystian Jazdzewski; Tomasz Bednarczuk; Magdalena Stepnowska; Sandya Liyanarachchi; Krystyna Suchecka-Rachon; Janusz Limon; Krzysztof Narkiewicz
Journal:  Int J Mol Med       Date:  2007-01       Impact factor: 4.101

2.  Single-nucleotide polymorphisms in the β-adrenergic receptor genes are associated with lung allograft utilization.

Authors:  Anil Sapru; Ludmila Pawlikowska; Kathleen D Liu; Kiran K Khush; Lee Ann-Baxter-Lowe; Vanessa Hayden; Rebecca L Menza; Maureen Convery; Annie Poon; Megan Landeck; Jonathan G Zaroff; Michael A Matthay
Journal:  J Heart Lung Transplant       Date:  2011-02       Impact factor: 10.247

3.  A common β1-adrenergic receptor polymorphism predicts favorable response to rate-control therapy in atrial fibrillation.

Authors:  Babar Parvez; Nagesh Chopra; Shane Rowan; Joseph C Vaglio; Raafia Muhammad; Dan M Roden; Dawood Darbar
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

4.  beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.

Authors:  M A Pacanowski; Y Gong; R M Cooper-Dehoff; N J Schork; M D Shriver; T Y Langaee; C J Pepine; J A Johnson
Journal:  Clin Pharmacol Ther       Date:  2008-07-09       Impact factor: 6.875

Review 5.  Genomics, heart failure and sudden cardiac death.

Authors:  Dawood Darbar
Journal:  Heart Fail Rev       Date:  2008-04-24       Impact factor: 4.214

6.  The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker.

Authors:  Orly Vardeny; Michelle A Detry; John J M Moran; Maryl R Johnson; Nancy K Sweitzer
Journal:  J Cardiovasc Pharmacol       Date:  2008-12       Impact factor: 3.105

Review 7.  Rescue of familial cardiomyopathies by modifications at the level of sarcomere and Ca2+ fluxes.

Authors:  Marco L Alves; Robert D Gaffin; Beata M Wolska
Journal:  J Mol Cell Cardiol       Date:  2010-01-15       Impact factor: 5.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.